Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Varian Medical Systems (VAR) Share Price

News headlines about Varian Medical Systems (NYSE:VAR) have been trending somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Varian Medical Systems earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 45.5967229759177 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the media headlines that may have effected Accern’s rankings:

Shares of Varian Medical Systems (NYSE VAR) traded down $3.04 during midday trading on Friday, hitting $108.49. The stock had a trading volume of 1,462,201 shares, compared to its average volume of 634,874. Varian Medical Systems has a 52 week low of $75.54 and a 52 week high of $114.09. The stock has a market capitalization of $9,940.00, a price-to-earnings ratio of 39.31, a price-to-earnings-growth ratio of 3.28 and a beta of 0.68.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The business had revenue of $739.00 million for the quarter, compared to analysts’ expectations of $741.69 million. During the same period in the previous year, the firm posted $1.03 EPS. The firm’s revenue for the quarter was down 1.1% compared to the same quarter last year. sell-side analysts predict that Varian Medical Systems will post 4.25 EPS for the current fiscal year.

A number of research firms have weighed in on VAR. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Evercore ISI began coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 target price for the company. Citigroup lifted their target price on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a report on Monday, October 30th. Royal Bank of Canada set a $105.00 target price on Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Finally, Zacks Investment Research lowered Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $100.44.

In other news, EVP Kolleen T. Kennedy sold 931 shares of the business’s stock in a transaction dated Wednesday, October 18th. The stock was sold at an average price of $105.00, for a total transaction of $97,755.00. Following the completion of the transaction, the executive vice president now owns 27,531 shares of the company’s stock, valued at $2,890,755. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy E. Guertin sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $111.46, for a total value of $1,114,600.00. Following the completion of the sale, the director now directly owns 2,161 shares of the company’s stock, valued at approximately $240,865.06. The disclosure for this sale can be found here. Insiders have sold 111,727 shares of company stock valued at $12,392,515 in the last three months. 0.78% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: This article was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.com-unik.info/2018/01/13/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-varian-medical-systems-var-share-price.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit